Insiders · CLBS

CLBS insider transactions

Caladrius Biosciences Inc. (CLBS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CLBS

• 1194d
  SEC Form 4: Mazzo David J covered exercise/tax liability with 397 shares, decreasing direct ownership by 0.41% to 96,543 units

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1199d
  SEC Form 4: Mazzo David J covered exercise/tax liability with 1,030 shares, decreasing direct ownership by 1% to 96,940 units

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1200d
  SEC Form 4: Ruoslahti Erkki was granted 20,000 shares

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1200d
  SEC Form 4: Klosk Steven M was granted 20,000 shares, increasing direct ownership by 198% to 30,090 units

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1200d
  SEC Form 4: Henson Heidi was granted 20,000 shares

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1200d
  SEC Form 4: Flowers Cynthia Louise was granted 20,000 shares, increasing direct ownership by 206% to 29,721 units

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1200d
  SEC Form 4: Brown Gregory B was granted 20,000 shares, increasing direct ownership by 201% to 29,934 units

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1200d
  SEC Form 4: Azab Mohammad was granted 20,000 shares, increasing direct ownership by 104% to 39,200 units

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1200d
  SEC Form 4: Slack David W. was granted 24,000 shares and covered exercise/tax liability with 3,358 shares

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1200d
  SEC Form 4: Mazzo David J was granted 60,000 shares and covered exercise/tax liability with 11,315 shares, increasing direct ownership by 99% to 97,970 units

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1200d
  SEC Form 4: Buck Kristen K was granted 18,000 shares and covered exercise/tax liability with 2,659 shares, increasing direct ownership by 75% to 35,823 units

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1317d
  SEC Form 3 filed by new insider Slack David W.

  3 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1317d
  SEC Form 3: New insider Ruoslahti Erkki claimed ownership of 1,171,144 shares

  3 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1317d
  SEC Form 3 filed by new insider Henson Heidi

  3 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1317d
  SEC Form 4: Azab Mohammad was granted 19,200 shares

  4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1317d
  SEC Form 3 filed by new insider Azab Mohammad

  3 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
• 1331d
  SEC Form 4: Buck Kristen K was granted 58,000 shares and covered exercise/tax liability with 69,959 shares, decreasing direct ownership by 4% to 307,244 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1331d
  SEC Form 4: Mazzo David J was granted 150,000 shares and covered exercise/tax liability with 69,742 shares, increasing direct ownership by 12% to 739,444 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1558d
  SEC Form 4: Mazzo David J covered exercise/tax liability with 13,082 shares, decreasing direct ownership by 2% to 631,065 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1558d
  SEC Form 4: Girolamo Todd C covered exercise/tax liability with 4,721 shares, decreasing direct ownership by 3% to 160,827 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1564d
  SEC Form 4: Mazzo David J was granted 401,000 shares and covered exercise/tax liability with 73,150 shares, increasing direct ownership by 104% to 644,147 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1564d
  SEC Form 4: Girolamo Todd C was granted 129,000 shares and covered exercise/tax liability with 22,127 shares, increasing direct ownership by 182% to 165,548 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1564d
  SEC Form 4: Buck Kristen K was granted 64,500 shares and covered exercise/tax liability with 7,694 shares, increasing direct ownership by 22% to 319,203 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1564d
  SEC Form 4: Whitaker Anne Clem was granted 65,430 shares, increasing direct ownership by 56% to 182,635 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1564d
  SEC Form 4: Traber Peter G was granted 65,430 shares, increasing direct ownership by 78% to 149,190 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1564d
  SEC Form 4: Myers Steven S was granted 65,430 shares, increasing direct ownership by 45% to 212,269 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1564d
  SEC Form 4: Klosk Steven M was granted 65,430 shares, increasing direct ownership by 76% to 151,390 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1564d
  SEC Form 4: Flowers Cynthia Louise was granted 65,430 shares, increasing direct ownership by 81% to 145,847 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1564d
  SEC Form 4: Davidson Michael H. was granted 65,430 shares, increasing direct ownership by 45% to 209,753 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1564d
  SEC Form 4: Brown Gregory B was granted 65,430 shares, increasing direct ownership by 78% to 149,040 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1597d
  SEC Form 4: Myers Steven S bought $30,190 worth of shares (33,785 units at $0.89), increasing direct ownership by 30% to 146,839 units

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1629d
  SEC Form 3 filed by new insider Girolamo Todd C

  3 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1695d
  SEC Form 4: Buck Kristen K was granted 312,500 units of Common Stock and covered exercise/tax liability with 50,103 units of Common Stock

  4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
• 1695d
  SEC Form 3 filed by new insider Buck Kristen K

  3 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)